🇺🇸 FDA
Pipeline program

nasogastric tube decompression

NCC2025C1365

Phase 2 other active

Quick answer

nasogastric tube decompression for Pancreaticoduodenectomy is a Phase 2 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Pancreaticoduodenectomy
Phase
Phase 2
Modality
other
Status
active

Clinical trials